Day One released end of trial data, our dipg will be interim. That said with no approved dipg drugs and having fast track if the data on 20+ patients demonstrates significant dfp at 6 months we may get to lodge an nda. Fingers crossed, tho if the data is good you'd hope that Day One add it to their portfolio of kids cancer drugs.